Joinn Laboratories (China) Co (SHSE:603127) Debt-to-Equity : 0.01 (As of Mar. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Joinn Laboratories (China) Co Debt-to-Equity?

Joinn Laboratories (China) Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ¥28 Mil. Joinn Laboratories (China) Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ¥36 Mil. Joinn Laboratories (China) Co's Total Stockholders Equity for the quarter that ended in Mar. 2024 was ¥7,993 Mil. Joinn Laboratories (China) Co's debt to equity for the quarter that ended in Mar. 2024 was 0.01.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Joinn Laboratories (China) Co's Debt-to-Equity or its related term are showing as below:

SHSE:603127' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.01 Med: 0.01 Max: 0.31
Current: 0.01

During the past 12 years, the highest Debt-to-Equity Ratio of Joinn Laboratories (China) Co was 0.31. The lowest was 0.01. And the median was 0.01.

SHSE:603127's Debt-to-Equity is ranked better than
99.48% of 194 companies
in the Medical Diagnostics & Research industry
Industry Median: 0.225 vs SHSE:603127: 0.01

Joinn Laboratories (China) Co Debt-to-Equity Historical Data

The historical data trend for Joinn Laboratories (China) Co's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Joinn Laboratories (China) Co Debt-to-Equity Chart

Joinn Laboratories (China) Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

Get a 7-Day Free Trial

0.03

0.08

0.01

Joinn Laboratories (China) Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Debt-to-Equity	Get a 7-Day Free Trial															0.01	0.01	0.01	0.01	0.01

Competitive Comparison of Joinn Laboratories (China) Co's Debt-to-Equity

For the Diagnostics & Research subindustry, Joinn Laboratories (China) Co's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Joinn Laboratories (China) Co's Debt-to-Equity Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Joinn Laboratories (China) Co's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Joinn Laboratories (China) Co's Debt-to-Equity falls into.

Joinn Laboratories (China) Co Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Joinn Laboratories (China) Co's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(27.5	+	41.925)	/	8279.316
	=	0.01

Joinn Laboratories (China) Co's Debt to Equity Ratio for the quarter that ended in Mar. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(27.964	+	35.532)	/	7993.145
	=	0.01

Joinn Laboratories (China) Co (SHSE:603127) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Joinn Laboratories (China) Co Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Joinn Laboratories (China) Co's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Joinn Laboratories (China) Co (SHSE:603127) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Joinn Laboratories (China) Co Ltd (SHSE:603127) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

06127:Hong Kong

Address

A5 Rongjing East Street, Beijing Economic-Technological Development Area, Beijing, CHN, 100176

Website

https://www.joinnlabs.com

Joinn Laboratories (China) Co Ltd is a non-clinical contract research organization(CRO) focused on drug safety assessment. It operates in three segments: Non-clinical studies services include drug safety assessment, drug metabolism & pharmacokinetics (DMPK) studies, & pharmacology & efficacy studies; Clinical trial & related services segment provides early-stage services such as clinical CRO services, co-managed phase I clinical research units, & bioanalytical services, and: Sales of research models engages in the design, production, breeding, & sales of research models, currently including non-human primates and rodents. The majority is from the Non- Clinical studies services. Its geographical segments are China, the United States, and Other countries, of which the majority is from China.

Joinn Laboratories (China) Co (SHSE:603127) Headlines

No Headlines